Mariana Tannus Ruckert

6PUBLICATIONS
38CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 21, 2026
Asynchronous evolution of epithelium and stroma differentiates precursor lesions from pancreatic cancer.

|Apr 01, 2026
NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions.

Megan D Radyk, Barbara S Nelson, Mariana Tannus Ruckert

|Mar 22, 2025
Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer.

Richard McKinnon Walsh, Joseph Ambrose, Jarrid L Jack

|Jul 24, 2024
Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation.

Verena Silva Santos, Gabriela Maciel Vieira, Mariana Tannús Ruckert

|Feb 22, 2022
Correction: Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.

Sharon J Manley, Appolinaire A Olou, Jarrid L Jack

|Feb 05, 2022
Synthetic adiponectin-receptor agonist, AdipoRon, induces glycolytic dependence in pancreatic cancer cells.

Sharon J Manley, Appolinaire A Olou, Jarrid L Jack

Pageof 1

Frequent Collaborators

3 joint publications

Michael N VanSaun

2 joint publications

Sharon J Manley

2 joint publications

Shrikant Anant

2 joint publications

Costas A Lyssiotis